family No. | patient | gender | age at onset(y) | site of onset | Clinical phenotype | EMG test | survival(m) | gene mutation |
---|---|---|---|---|---|---|---|---|
family 1 | I1 | male | 60 | bulbar | NA | NA | 72 | NA |
II3 | male | 58 | bulbar | LMN + UMN | M,C,T,L | 108 | TARDBP:c.1009A > G,p.M337 V | |
family 2 | II2 | female | 60 | bulbar | NA | NA | 144 | NA |
II4 | female | 58 | bulbar | LMN-dominant | M,C,T,L | 120 | TARDBP:c.1009A > G,p.M337 V | |
II6 | female | 59 | upper limb | LMN + UMN | M,C,T,L | > 52 | TARDBP:c.1009A > G,p.M337 V | |
family 3 | II2 | male | 50 | upper limb | NA | NA | 36 | NA |
II4 | male | 62 | upper limb | LMN + UMN | C,T,L | 84 | TARDBP:c.1009A > G,p.M337 V | |
II5 | female | 61 | lower limb | UMN-dominant | M,C,T,L | > 68 | TARDBP:c.1009A > G,p.M337 V | |
family 4 | I1 | male | 62 | bulbar | NA | NA | 168 | NA |
II4 | male | 54 | bulbar | LMN + UMN | M,C,T,L | > 64 | TARDBP:c.1009A > G,p.M337 V | |
II5 | male | no symptoms | TARDBP:c.1009A > G,p.M337 V | |||||
family 5 | I1 | male | 50 | upper limb | NA | NA | 120 | NA |
II5 | male | 50 | upper limb | LMN-dominant | M,C,T,L | > 59 | TARDBP:c.1042G > T,p.G348C |